Skip to main content
Clinical Trials/NCT02274246
NCT02274246
Completed
Phase 1

GIMIAS® Tool Validation for the Detection of Left Atrium Fibrosis Through Late Enhancement Magnetic Resonance Image Processing. Pattern Determination in a Cohort of Healthy Volunteers

Fundacion Clinic per a la Recerca Biomédica1 site in 1 country9 target enrollmentStarted: November 2014Last updated:
Interventionsgadobutrol

Overview

Phase
Phase 1
Status
Completed
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Enrollment
9
Locations
1
Primary Endpoint
Proportion of subjects with contrast enhancement in left atrium, measured through the reconstruction and processing of late enhancement magnetic resonance images with GIMIAS.

Overview

Brief Summary

The purpose of this study is to validate the technique for the detection of left atrial fibrosis through segmentation of endocardial and epicardium landmarks of the images obtained with 3 Tgadobutrol-enhanced magnetic resonance with the software GIMIAS® in a cohort of healthy volunteers, without atrial fibrillation or known cardiovascular risk factors.

Detailed Description

3D reconstructions obtained by GIMIAS® will be evaluated. Processing images will be carried out by two independent operators, and will calculate the kappa interobserver agreement .

Subsequently, the processed images are compared with images previously obtained in 10 patients with persistent atrial fibrillation adjusted for sex and age. A qualitative visual comparison will be made.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy volunteers capable of being subjected to the prespecified tests of the study.
  • Healthy volunteers that sign the informed consent after being informed.

Exclusion Criteria

  • Healthy volunteers with:
  • A medical history of atrial fibrillation, hypertension or diabetes mellitus.
  • A medical history of heart disease, structural, ischemic or arrhythmic.
  • A medical history of chronic obstructive pulmonary disease/obstructive sleep apnoea/hypopnoea syndrome
  • Sport habits: intense sport activities during three or more hours in a week
  • Any assumption that contraindicates the magnetic resonance and/or the use of gadolinium or other contrast mediums, including a medical history of previous allergic or not allergic reactions with the use of gadolinium or other contrast mediums, bronchial asthma or allergic diseases.
  • Pregnancy or breast feeding.

Arms & Interventions

Gadobutrol

Experimental

Gadobutrol in Healthy volunteers

Intervention: gadobutrol (Drug)

Outcomes

Primary Outcomes

Proportion of subjects with contrast enhancement in left atrium, measured through the reconstruction and processing of late enhancement magnetic resonance images with GIMIAS.

Time Frame: Baseline

Secondary Outcomes

  • Interobserver variability in the generation of segmented images of left atrium, measured through the kappa index.(1 week after intervention)
  • Adverse events(1 week after intervention)

Investigators

Sponsor
Fundacion Clinic per a la Recerca Biomédica
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sara Varea

Clinical Research Manager

Fundacion Clinic per a la Recerca Biomédica

Study Sites (1)

Loading locations...

Similar Trials